Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: how should rifabutin be managed in rescue regimens?

被引:6
作者
Losurdo, Giuseppe [1 ]
Iannone, Andrea [1 ]
Giorgio, Floriana [1 ]
Principi, Mariabeatrice [1 ]
Di Leo, Alfredo [1 ]
Ierardi, Enzo [1 ]
机构
[1] Univ Bari, Gastroenterol Sect, Dept Emergency & Organ Transplantat, Piazza Giulio Cesare, I-70124 Bari, Italy
关键词
Helicobacter pylori; rifabutin; antibiotic resistance; rescue regimens; CONSENSUS REPORT; INFECTION; TUBERCULOSIS; RESISTANCE;
D O I
10.1177/2050640615623697
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:474 / 475
页数:2
相关论文
共 12 条
[1]   Culture-guided treatment approach for Helicobacter pylori infection: Review of the literature [J].
Cammarota, Giovanni ;
Ianiro, Gianluca ;
Bibbo, Stefano ;
Di Rienzo, Teresa Antonella ;
Masucci, Luca ;
Sanguinetti, Maurizio ;
Gasbarrini, Antonio .
WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (18) :5205-5211
[2]   Predicting differential rifamycin resistance in clinical Mycobacterium tuberculosis isolates by specific rpoB mutations [J].
ElMaraachli, W. ;
Slater, M. ;
Berrada, Z. L. ;
Lin, S-Y. G. ;
Catanzaro, A. ;
Desmond, E. ;
Rodrigues, C. ;
Victor, T. C. ;
Crudu, V. ;
Gler, M. T. ;
Rodwell, T. C. .
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2015, 19 (10) :1222-1226
[3]   Review article: rifabutin in the treatment of refractory Helicobacter pylori infection [J].
Gisbert, J. P. ;
Calvet, X. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (02) :209-221
[4]   ADVERSE EVENTS ASSOCIATED WITH HIGH-DOSE RIFABUTIN IN MACROLIDE-CONTAINING REGIMENS FOR THE TREATMENT OF MYCOBACTERIUM-AVIUM COMPLEX LUNG-DISEASE [J].
GRIFFITH, DE ;
BROWN, BA ;
GIRARD, WM ;
WALLACE, RJ .
CLINICAL INFECTIOUS DISEASES, 1995, 21 (03) :594-598
[5]  
Ierardi E, 2014, J GASTROINTEST LIVER, V23, P367, DOI 10.15403/jgld.2014.1121.234.qrth
[6]   How antibiotic resistances could change Helicobacter pylori treatment: A matter of geography? [J].
Ierardi, Enzo ;
Giorgio, Floriana ;
Losurdo, Giuseppe ;
Di Leo, Alfredo ;
Principi, Mariabeatrice .
WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (45) :8168-8180
[7]   Management of Helicobacter pylori infection-the Maastricht IV/ Florence Consensus Report [J].
Malfertheiner, Peter ;
Megraud, Francis ;
O'Morain, Colm A. ;
Atherton, John ;
Axon, Anthony T. R. ;
Bazzoli, Franco ;
Gensini, Gian Franco ;
Gisbert, Javier P. ;
Graham, David Y. ;
Rokkas, Theodore ;
El-Omar, Emad M. ;
Kuipers, Ernst J. .
GUT, 2012, 61 (05) :646-664
[8]   Resistance of Helicobacter pylori to antibiotics and its impact on treatment options [J].
Mégraud, F .
DRUG RESISTANCE UPDATES, 2001, 4 (03) :178-186
[9]   Randomized trial of rifabutin-based triple therapy and high-dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin [J].
Miehlke, S. ;
Hansky, K. ;
Schneider-Brachert, W. ;
Kirsch, C. ;
Morgner, A. ;
Madisch, A. ;
Kuhlisch, E. ;
Baestlein, E. ;
Jacobs, E. ;
Bayerdoerffer, E. ;
Lehn, N. ;
Stolte, M. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 24 (02) :395-403
[10]   Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study [J].
Mori, Hideki ;
Suzuki, Hidekazu ;
Matsuzaki, Juntaro ;
Tsugawa, Hitoshi ;
Fukuhara, Seiichiro ;
Miyoshi, Sawako ;
Hirata, Kenro ;
Seino, Takashi ;
Matsushita, Misako ;
Nishizawa, Toshihiro ;
Masaoka, Tatsuhiro ;
Kanai, Takanori .
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2016, 4 (03) :380-387